Cannabinoid receptor 2 deficiency exacerbates inflammation and neutrophil recruitment.

Cannabinoid receptor 2 deficiency exacerbates inflammation and neutrophil recruitment.

Cannabinoid receptor (CB)2 is an immune cell-localized GPCR that has been hypothesized to regulate the magnitude of inflammatory responses. However, there is currently no consensus as to the mechanism by which CB2 mediates its anti-inflammatory effects in vivo. To address this question, we employed...

Bibliografske podrobnosti
Main Authors:	Kapellos, T, Taylor, L, Feuerborn, A, Valaris, S, Hussain, M, Rainger, G, Greaves, D, Iqbal, A
Drugi avtorji:	Needham, G
Format:	Journal article
Jezik:	English
Izdano:	Federation of American Society of Experimental Biology 2019

Podobne knjige/članki

Cannabinoid receptor 2 modulates neutrophil recruitment in a murine model of endotoxemia.
od: Kapellos, T, et al.
Izdano: (2017)

Critical assessment of the role of cannabinoid receptor 2 in inflammation
od: Kapellos, T
Izdano: (2016)

Absence of the non-signalling chemerin receptor CCRL2 exacerbates acute inflammatory responses in vivo
od: Regan-Komito, D, et al.
Izdano: (2017)

Assessment of the role of cannabinoid receptor 2 in innate immune cell trafficking during acute inflammation
od: Taylor, L
Izdano: (2016)

The role of chemerin and chemerin receptors during acute inflammation
od: Valaris, S
Izdano: (2017)

Macrophages in the synovial lining niche initiate neutrophil recruitment and articular inflammation
od: Zec, K, et al.
Izdano: (2023)

Murine Chemerin (T-20-S-156) enhances the resolution of inflammation in a murine model of zymosan induced peritonitis
od: Regan-Komito, D, et al.
Izdano: (2014)

Toll-like receptor responses in IRAK-4-deficient neutrophils.
od: van Bruggen, R, et al.
Izdano: (2010)

Epigenetic control of macrophage polarisation and soluble mediator gene expression during inflammation
od: Kapellos, T, et al.
Izdano: (2016)

The role of metabolite-sensing G protein-coupled receptors in inflammation and metabolic disease
od: Recio, C, et al.
Izdano: (2018)

Ligand-based virtual screening identifies a family of selective cannabinoid receptor 2 agonists.
od: Gianella-Borradori, M, et al.
Izdano: (2015)

Marijuana and the cannabinoids /
od: ElSohly, Mahmoud A.
Izdano: (2007)

Estrogen exacerbates mammary involution through neutrophil-dependent and -independent mechanism
od: Lim, Chew Leng, et al.
Izdano: (2020)

Estrogen exacerbates mammary involution through neutrophil-dependent and -independent mechanism
od: Lim, Chew Leng, et al.
Izdano: (2020)

Estrogen exacerbates mammary involution through neutrophil-dependent and -independent mechanism
od: Lim, Chew Leng, et al.
Izdano: (2020)

CC chemokine receptors and chronic inflammation--therapeutic opportunities and pharmacological challenges.
od: White, G, et al.
Izdano: (2013)

CB1 and CB2 cannabinoid receptors are implicated in inflammatory pain.
od: Clayton, N, et al.
Izdano: (2002)

Macrophage-derived human resistin exacerbates adipose tissue inflammation and insulin resistance in mice.
od: Qatanani, M, et al.
Izdano: (2009)

Glycosaminoglycans are important mediators of neutrophilic inflammation in vivo
od: Gschwandtner, M, et al.
Izdano: (2016)

Cannabinoid type 1 receptor antagonists for smoking cessation.
od: Cahill, K, et al.
Izdano: (2011)

Cannabinoid type 1 receptor antagonists for smoking cessation.
od: Cahill, K, et al.
Izdano: (2011)

Key transcriptional regulators of neutrophil function in inflammation
od: Ai, Z
Izdano: (2021)

Leucocyte recruitment and inflammation in the CNS.
od: Sloan, D, et al.
Izdano: (1992)

CB1 and CB2 cannabinoid receptors are implicated in inflammatory hypersensitivity to pain
od: Clayton, N, et al.
Izdano: (2001)

Cannabinoid Receptor 1 Is Required for Neurodevelopment of Striosome-Dendron Bouquets
od: Crittenden, Jill R, et al.
Izdano: (2023)

Cannabinoid type 1 receptor antagonists (rimonabant) for smoking cessation.
od: Cahill, K, et al.
Izdano: (2007)

Intact cannabinoid CB1 receptors in the Alzheimer's disease cortex
od: Lee, J, et al.
Izdano: (2010)

Cannabinoid type 1 receptor antagonists (rimonabant) for smoking cessation.
od: Cahill, K, et al.
Izdano: (2007)

Cannabinoid type 1 receptor antagonists (rimonabant) for smoking cessation.
od: Cahill, K, et al.
Izdano: (2007)

Intact cannabinoid CB1 receptors in the Alzheimer's disease cortex.
od: Lee, J, et al.
Izdano: (2010)

Cannabinoid 1 receptors are expressed in nociceptive primary sensory neurons.
od: Ahluwalia, J, et al.
Izdano: (2000)

Bruton's TK regulates myeloid cell recruitment during acute inflammation
od: Purvis, GSD, et al.
Izdano: (2022)

IRF5 controls macrophage-neutrophil axis in inflammation
od: Udalova, I
Izdano: (2014)

Transcriptional regulation of neutrophil differentiation and function during inflammation
od: Ai, Z, et al.
Izdano: (2020)

Eosinophilic airway inflammation and exacerbations of COPD: a randomised controlled trial.
od: Siva, R, et al.
Izdano: (2007)

Interleukin-6 deficiency exacerbates Huntington’s disease model phenotypes
od: Wertz, Mary H., et al.
Izdano: (2020)

Ghrelin and cannabinoids require the ghrelin receptor to affect cellular energy metabolism.
od: Lim, C, et al.
Izdano: (2013)

Ghrelin and cannabinoids require the ghrelin receptor to affect cellular energy metabolism
od: Lim, C, et al.
Izdano: (2013)

Exacerbated hematopoietic stem and progenitor cell activity during intestinal inflammation
od: Griseri, T, et al.
Izdano: (2011)

HYPOXIA-INDUCIBLE FACTOR 2 alpha REGULATES NEUTROPHILIC INFLAMMATION IN HUMANS, MICE AND ZEBRAFISH
od: Thompson, A, et al.
Izdano: (2012)